Cargando…

Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis

OBJECTIVE: Pulmonary aspergillosis is a rare but challenging pulmonary disease. The conditions of patients with chronic pulmonary aspergillosis (CPA) can be even more complicated. The mortality rate of CPA remains high, and the prognostic factors are not well established due to a high proportion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shaoqiang, Li, Ya, Li, Zhengtu, Yang, Xin, Zhan, Yangqing, Li, Weilong, Lin, Ye, Ye, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792682/
https://www.ncbi.nlm.nih.gov/pubmed/36582375
http://dx.doi.org/10.3389/fpubh.2022.1026855
_version_ 1784859688857239552
author Li, Shaoqiang
Li, Ya
Li, Zhengtu
Yang, Xin
Zhan, Yangqing
Li, Weilong
Lin, Ye
Ye, Feng
author_facet Li, Shaoqiang
Li, Ya
Li, Zhengtu
Yang, Xin
Zhan, Yangqing
Li, Weilong
Lin, Ye
Ye, Feng
author_sort Li, Shaoqiang
collection PubMed
description OBJECTIVE: Pulmonary aspergillosis is a rare but challenging pulmonary disease. The conditions of patients with chronic pulmonary aspergillosis (CPA) can be even more complicated. The mortality rate of CPA remains high, and the prognostic factors are not well established due to a high proportion of loss to follow-up. In this study, we aim to explore factors associated with loss to follow-up in CPA patients and their impact on the disease prognosis after withdrawing anti-fungal treatments. METHODS: Patients with confirmed CPA, who were admitted to the Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University from March 2017 to November 2019, were enrolled in this prospective study. The enrolled patients were followed up for 6 months after discharge. For loss to follow-up patients, the reasons for loss to follow-up and their prognosis after withdrawing anti-fungal treatments during loss to follow-up were recorded by telephone communication. Multivariate logistic regression analysis was performed to determine factors associated with loss to follow-up. RESULTS: The 199 out of 298 screened patients were included in the study. Except for 67 cases with regular follow-up, the rest 132 cases were lost to follow-up. Factors, including age > 60 years (OR = 2.036, P = 0.03), monthly income ≤ $583 (OR = 5.568, P = 0.0001), education ≤ 6 years (OR = 7.474, P = 0.0001), and non-local residence (OR = 5.893, P = 0.0001) were associated with the loss to follow-up according to multivariate logistic regression analysis. The most common reasons for loss to follow-up were economic factors and clinic visit distance. The overall case fatality rate (CFR) within 180 days in patients with regular follow-up and patients who stopped anti-fungal treatment during the loss to follow-up was 0% and 19.65%, respectively. CONCLUSION: The proportion of loss to follow-up in CPA patients remained high. Age (>60 years), poor financial status, low education, and non-local residence were the key factors associated with the loss to follow-up in this study. Our study reveals the need to optimize the follow-up procedures and improve the patients understanding about the benefits and limitations of follow-up to reduce the CFR.
format Online
Article
Text
id pubmed-9792682
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97926822022-12-28 Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis Li, Shaoqiang Li, Ya Li, Zhengtu Yang, Xin Zhan, Yangqing Li, Weilong Lin, Ye Ye, Feng Front Public Health Public Health OBJECTIVE: Pulmonary aspergillosis is a rare but challenging pulmonary disease. The conditions of patients with chronic pulmonary aspergillosis (CPA) can be even more complicated. The mortality rate of CPA remains high, and the prognostic factors are not well established due to a high proportion of loss to follow-up. In this study, we aim to explore factors associated with loss to follow-up in CPA patients and their impact on the disease prognosis after withdrawing anti-fungal treatments. METHODS: Patients with confirmed CPA, who were admitted to the Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University from March 2017 to November 2019, were enrolled in this prospective study. The enrolled patients were followed up for 6 months after discharge. For loss to follow-up patients, the reasons for loss to follow-up and their prognosis after withdrawing anti-fungal treatments during loss to follow-up were recorded by telephone communication. Multivariate logistic regression analysis was performed to determine factors associated with loss to follow-up. RESULTS: The 199 out of 298 screened patients were included in the study. Except for 67 cases with regular follow-up, the rest 132 cases were lost to follow-up. Factors, including age > 60 years (OR = 2.036, P = 0.03), monthly income ≤ $583 (OR = 5.568, P = 0.0001), education ≤ 6 years (OR = 7.474, P = 0.0001), and non-local residence (OR = 5.893, P = 0.0001) were associated with the loss to follow-up according to multivariate logistic regression analysis. The most common reasons for loss to follow-up were economic factors and clinic visit distance. The overall case fatality rate (CFR) within 180 days in patients with regular follow-up and patients who stopped anti-fungal treatment during the loss to follow-up was 0% and 19.65%, respectively. CONCLUSION: The proportion of loss to follow-up in CPA patients remained high. Age (>60 years), poor financial status, low education, and non-local residence were the key factors associated with the loss to follow-up in this study. Our study reveals the need to optimize the follow-up procedures and improve the patients understanding about the benefits and limitations of follow-up to reduce the CFR. Frontiers Media S.A. 2022-12-13 /pmc/articles/PMC9792682/ /pubmed/36582375 http://dx.doi.org/10.3389/fpubh.2022.1026855 Text en Copyright © 2022 Li, Li, Li, Yang, Zhan, Li, Lin and Ye. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Li, Shaoqiang
Li, Ya
Li, Zhengtu
Yang, Xin
Zhan, Yangqing
Li, Weilong
Lin, Ye
Ye, Feng
Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
title Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
title_full Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
title_fullStr Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
title_full_unstemmed Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
title_short Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
title_sort loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792682/
https://www.ncbi.nlm.nih.gov/pubmed/36582375
http://dx.doi.org/10.3389/fpubh.2022.1026855
work_keys_str_mv AT lishaoqiang losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT liya losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT lizhengtu losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT yangxin losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT zhanyangqing losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT liweilong losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT linye losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis
AT yefeng losstofollowupassociatedfactorsinpatientswithchronicpulmonaryaspergillosisanditsimpactonthediseaseprognosis